True resistant hypertension is rare (<5%) once pseudo-resistance (non-adherence, white-coat effect) and secondary causes are excluded, highlighting the importance of thorough diagnostic evaluation before escalating therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rainer Düsing (2020) conducted a review in Resistant and refractory hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: